Boston, MANCT06944145Now EnrollingIRB Ready

BPH (Benign Prostatic Hyperplasia) Clinical Trial in Boston, MA

Access cutting-edge bph (benign prostatic hyperplasia) treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Beth Israel Deaconess Medical Center

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access bph (benign prostatic hyperplasia) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bph (benign prostatic hyperplasia) treatment provided free

Apply for This Boston Location

Check if you qualify for this bph (benign prostatic hyperplasia) clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This BPH (Benign Prostatic Hyperplasia) Study in Boston

SRD5A2 is a critical enzyme for prostatic development and growth, and the SRD5A2 inhibitor, finasteride, is used to treat benign prostatic hyperplasia (BPH). SRD5A2 is absent in 30% of normal adult men, which explains the resistance of a subset of patients to this commonly prescribed drug. This project proposes new combination therapies (5-ARI+raloxifene) and evaluates novel non-invasive biomarkers, based on alternative pathways that lead to prostatic enlargement.

Sponsor: Beth Israel Deaconess Medical Center

Who Can Participate

Inclusion Criteria

≥18 yrs old on the day of study consent;
Finasteride has been recommended for treatment of BPH by a physician;
PSA \<20ng/ml within the last six months;
Willingness to maintain any current genitourinary medications (e.g., beta agonists, alpha blockers, anticholinergics);
Patient is able and willing to provide written informed consent.

Exclusion Criteria

Active or past history of venous thromboembolism, including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis;
Previous diagnosis with any prostatic malignancy or precancerous lesions (atypical glandular foci);
History of pelvic radiation;
Actively receiving intravesical therapy for bladder cancer;
Received treatment with any demethylating medications (azacitidine, decitabine, zebularine, guadecitabine, hydralazine);
Current use of warfarin;
Prior treatment with 5ARI medications (e.g., Finasteride or Dutasteride) in the last year;
Diagnosed with diabetes mellitus;
Diagnosed with any neurodegenerative diseases;
History of allergic reaction to any intravenous (IV) iron replacement products;
Currently taking cholestyramine medication;
Contraindications to MRI examination, which may include:
Cardiac pacemaker
Intracranial clips, metal implants, or external clips within 10mm of the head
Previous metal injury in the eye or occupation risk to ferrous metal in the eye (e.g. metalworker)
Claustrophobia that cannot be managed with benzodiazepine

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06944145) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

BPH (Benign Prostatic Hyperplasia) Treatment Options in Boston, MA

If you're searching for bph (benign prostatic hyperplasia) treatment options in Boston, MA, this clinical trial (NCT06944145) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bph (benign prostatic hyperplasia) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bph (benign prostatic hyperplasia) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Boston, MA

See all pulmonary embolism clinical trials recruiting in Boston — not just this study.

Browse Pulmonary Embolism Trials in Boston →

Browse More Trials by Condition

Pulmonary Embolism TrialsAnkylosing Spondylitis TrialsPulmonary Hypertension TrialsBenign Prostatic Hyperplasia TrialsInterstitial Cystitis TrialsRetinitis Pigmentosa TrialsRecurrent Pregnancy Loss TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA